A phase II trial of neoadjuvant docetaxel/5-FU/cisplatin in combination with prophylactic pegteograstim in unresectable, locally advanced nasal cavity/paranasal squamous cell carcinoma: KCSG HN18-07

被引：0
|
作者：
An, Hojung
Keam, Bhumsuk
Shin, Seong Hoon
Kim, Min Kyoung
Kim, Sung-Bae
机构：
[1] Catholic Univ Korea, St Vincents Hosp, Suwon, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[3] Kosin Univ, Gospel Hosp, Busan, South Korea
[4] Yeungnam Univ Univ Hosp, Daegu, South Korea
[5] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6020
引用
收藏
页数：1
相关论文
共 50 条
  • [31] TENERGY: Multicenter phase II study of atezolizumab monotherapy following definitive chemoradiotherapy with 5-FU plus cisplatin in patients with locally advanced esophageal squamous cell carcinoma.
    Bando, Hideaki
    Kotani, Daisuke
    Tsushima, Takahiro
    Hara, Hiroki
    Kadowaki, Shigenori
    Kato, Ken
    Chin, Keisho
    Yamaguchi, Kensei
    Kageyama, Shun-ichiro
    Hojo, Hidehiro
    Wakabayashi, Masashi
    Fukutani, Miki
    Togashi, Yosuke
    Fuse, Nozomu
    Nishikawa, Hiroyoshi
    Kojima, Takashi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] PHASE-II TRIAL WITH CARBOPLATIN/5-FU FOR PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    VOLLING, P
    SCHRODER, M
    RAUSCHNING, W
    ACHTERRATH, W
    STENNERT, E
    NAGEL, G
    HNO, 1988, 36 (11) : 452 - 455
  • [33] Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck
    Tahara, Makoto
    Minami, Hironobu
    Kawashima, Mitsuhiko
    Kawada, Kenji
    Mukai, Hirofumi
    Sakuraba, Minoru
    Matsuura, Kazuto
    Ogino, Takashi
    Hayashi, Ryuichi
    Ohtsu, Atsushi
    CANCER SCIENCE, 2011, 102 (02) : 419 - 424
  • [34] Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck
    Tsukuda M.
    Mikami Y.
    Tanigaki Y.
    Katori H.
    Horiuchi C.
    Ikeda Y.
    Taguchi T.
    Ono M.
    Yoshida T.
    Sakuma Y.
    Aikoh K.
    International Journal of Clinical Oncology, 2004, 9 (3) : 161 - 166
  • [35] Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck:: A randomised phase II study
    Fonseca, E
    Grau, JJ
    Sastre, J
    García-Gómez, JM
    Rueda, A
    Pastor, M
    Lara, MA
    Navalón, M
    Berrocal, A
    Tisaire, JL
    Cruz, JJ
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (09) : 1254 - 1260
  • [36] A Phase I/II Study of Second-Line Chemotherapy with Fractionated Docetaxel and Nedaplatin for 5-FU/Cisplatin-Resistant Esophageal Squamous Cell Carcinoma
    Akutsu, Yasunori
    Shuto, Kiyohiko
    Kono, Tsuguaki
    Uesato, Masaya
    Hoshino, Isamu
    Shiratori, Toru
    Miyazawa, Yukimasa
    Isozaki, Yuka
    Akanuma, Naoki
    Matsubara, Hisahiro
    HEPATO-GASTROENTEROLOGY, 2012, 59 (119) : 2095 - 2098
  • [37] Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC)
    Hitt, R.
    Grau, J. J.
    Lopez-Pousa, A.
    Berrocal, A.
    Garcia Giron, C.
    Irigoyen, A.
    Sastre, J.
    Martinez, J.
    Cortes-Funes, H.
    Cruz-Hernandez, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study
    Hihara, J.
    Hamai, Y.
    Emi, M.
    Murakami, Y.
    Kenjo, M.
    Nagata, Y.
    Okada, M.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (07): : 1115 - 1120
  • [39] Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: A phase II feasibility study
    Ghi, MG
    Paccagnella, A
    D'Amanzo, P
    Mione, CA
    Fasan, S
    Paro, S
    Mastromauro, C
    Carnuccio, R
    Turcato, G
    Gatti, C
    Pallini, A
    Nascimben, O
    Biason, R
    Oniga, F
    Medici, M
    Rossi, F
    Fila, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (02): : 481 - 487
  • [40] Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303
    Egloff, Ann Marie
    Lee, Ju-Whei
    Langer, Corey J.
    Quon, Harry
    Vaezi, Alec
    Grandis, Jennifer R.
    Seethala, Raja R.
    Wang, Lin
    Shin, Dong M.
    Argiris, Athanassios
    Yang, Donghua
    Mehra, Ranee
    Ridge, John Andrew
    Patel, Urjeet A.
    Burtness, Barbara A.
    Forastiere, Arlene A.
    CLINICAL CANCER RESEARCH, 2014, 20 (19) : 5041 - 5051
12345